# IDT Corp: financial statements, quarterly

IDT · NYSE · CIK 1005731 · [Communication](/sectors/communication.md) · fiscal year ends Jul 31

Pages: [Overview](/companies/idt.md) · [Financials](/companies/idt/financials.md) · [Filings](/companies/idt/filings.md) · [Insiders](/companies/idt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/idt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [301](/filings/0001493152-24-049468.md) | [296](/filings/0001493152-25-010016.md) | [300](/filings/0001641172-25-014351.md) | [309 d](/filings/0001493152-25-016071.md) | [310](/filings/0001493152-25-027060.md) | [303](/filings/0001493152-26-009820.md) | [302](/filings/0001641172-25-014351.md) | [317 d](/filings/0001493152-25-016071.md) | [323](/filings/0001493152-25-027060.md) | [321](/filings/0001493152-26-009820.md) | [316](/filings/0001437749-26-019975.md) | [339 d](/filings/0001437749-26-031469.md) |
| Cost of revenue | $m | [207](/filings/0001493152-24-049468.md) | [199](/filings/0001493152-25-010016.md) | [203](/filings/0001641172-25-014351.md) | [207 d](/filings/0001437749-26-031469.md) | [202](/filings/0001493152-25-027060.md) | [191](/filings/0001493152-26-009820.md) | [190](/filings/0001437749-26-019975.md) | [202 d](/filings/0001437749-26-031469.md) | [205](/filings/0001493152-25-027060.md) | [199](/filings/0001493152-26-009820.md) | [193](/filings/0001437749-26-019975.md) | [204 d](/filings/0001437749-26-031469.md) |
| Gross profit | $m | [94.0](/filings/0001493152-24-049468.md) | [96.9](/filings/0001493152-25-010016.md) | [97.0](/filings/0001641172-25-014351.md) | [102 d](/filings/0001437749-26-031469.md) | [108](/filings/0001493152-25-027060.md) | [112](/filings/0001493152-26-009820.md) | [112](/filings/0001437749-26-019975.md) | [114 d](/filings/0001437749-26-031469.md) | [118](/filings/0001493152-25-027060.md) | [121](/filings/0001493152-26-009820.md) | [123](/filings/0001437749-26-019975.md) | [135 d](/filings/0001437749-26-031469.md) |
| Research and development | $m | [12.4](/filings/0001493152-24-049468.md) | [12.9](/filings/0001493152-25-010016.md) | [12.6](/filings/0001641172-25-014351.md) | [12.6 d](/filings/0001437749-26-031469.md) | [12.8](/filings/0001493152-25-027060.md) | [12.6](/filings/0001493152-26-009820.md) | [12.7](/filings/0001437749-26-019975.md) | [12.8 d](/filings/0001437749-26-031469.md) | [13.6](/filings/0001493152-25-027060.md) | [14.1](/filings/0001493152-26-009820.md) | [13.9](/filings/0001437749-26-019975.md) | [14.0 d](/filings/0001437749-26-031469.md) |
| Selling, general and administrative | $m | [64.4](/filings/0001493152-24-049468.md) | [67.3](/filings/0001493152-25-010016.md) | [69.0](/filings/0001641172-25-014351.md) | [69.5 d](/filings/0001437749-26-031469.md) | [71.1](/filings/0001493152-25-027060.md) | [70.7](/filings/0001493152-26-009820.md) | [72.3](/filings/0001437749-26-019975.md) | [73.5 d](/filings/0001437749-26-031469.md) | [74.0](/filings/0001493152-25-027060.md) | [78.8](/filings/0001493152-26-009820.md) | [78.8](/filings/0001437749-26-019975.md) | [86.7 d](/filings/0001437749-26-031469.md) |
| Operating income | $m | [17.2](/filings/0001493152-24-049468.md) | [16.0](/filings/0001493152-25-010016.md) | [11.4](/filings/0001641172-25-014351.md) | [20.1 d](/filings/0001437749-26-031469.md) | [23.6](/filings/0001493152-25-027060.md) | [28.3](/filings/0001493152-26-009820.md) | [26.6](/filings/0001437749-26-019975.md) | [21.9 d](/filings/0001437749-26-031469.md) | [30.9](/filings/0001493152-25-027060.md) | [27.2](/filings/0001493152-26-009820.md) | [29.8](/filings/0001437749-26-019975.md) | [33.2 d](/filings/0001437749-26-031469.md) |
| Income tax | $m | [3.9](/filings/0001493152-24-049468.md) | [4.0](/filings/0001493152-25-010016.md) | [3.0](/filings/0001641172-25-014351.md) | [(17.3) d](/filings/0001437749-26-031469.md) | [6.3](/filings/0001493152-25-027060.md) | [7.7](/filings/0001493152-26-009820.md) | [7.8](/filings/0001437749-26-019975.md) | [2.9 d](/filings/0001437749-26-031469.md) | [8.1](/filings/0001493152-25-027060.md) | [6.2](/filings/0001493152-26-009820.md) | [8.5](/filings/0001437749-26-019975.md) | [12.1 d](/filings/0001437749-26-031469.md) |
| Net income | $m | [7.7](/filings/0001493152-24-049468.md) | [14.4](/filings/0001493152-25-010016.md) | [5.6](/filings/0001641172-25-014351.md) | [36.8 d](/filings/0001437749-26-031469.md) | [17.2](/filings/0001493152-25-027060.md) | [20.3](/filings/0001493152-26-009820.md) | [21.7](/filings/0001437749-26-019975.md) | [16.9 d](/filings/0001437749-26-031469.md) | [22.4](/filings/0001493152-25-027060.md) | [20.9](/filings/0001493152-26-009820.md) | [21.6](/filings/0001437749-26-019975.md) | [21.7 d](/filings/0001437749-26-031469.md) |
| Diluted EPS | $ per share | [0.30](/filings/0001493152-24-049468.md) | [0.57](/filings/0001493152-25-010016.md) | [0.22](/filings/0001641172-25-014351.md) | not reported | [0.68](/filings/0001493152-25-027060.md) | [0.80](/filings/0001493152-26-009820.md) | [0.86](/filings/0001437749-26-019975.md) | not reported | [0.89](/filings/0001493152-25-027060.md) | [0.84](/filings/0001493152-26-009820.md) | [0.87](/filings/0001437749-26-019975.md) | not reported |
| Basic EPS | $ per share | [0.30](/filings/0001493152-24-049468.md) | [0.57](/filings/0001493152-25-010016.md) | [0.22](/filings/0001641172-25-014351.md) | not reported | [0.68](/filings/0001493152-25-027060.md) | [0.81](/filings/0001493152-26-009820.md) | [0.86](/filings/0001437749-26-019975.md) | not reported | [0.89](/filings/0001493152-25-027060.md) | [0.84](/filings/0001493152-26-009820.md) | [0.87](/filings/0001437749-26-019975.md) | not reported |

- Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [122](/filings/0001493152-23-044374.md) | [141](/filings/0001493152-24-009529.md) | [140](/filings/0001493152-24-023350.md) | [165](/filings/0001493152-25-016071.md) | [148](/filings/0001493152-24-049468.md) | [142](/filings/0001493152-25-010016.md) | [200](/filings/0001641172-25-014351.md) | [227](/filings/0001437749-26-031469.md) | [189](/filings/0001493152-25-027060.md) | [210](/filings/0001493152-26-009820.md) | [215](/filings/0001437749-26-019975.md) | [221](/filings/0001437749-26-031469.md) |
| Current assets | $m | [382](/filings/0001493152-23-044374.md) | [408](/filings/0001493152-24-009529.md) | [409](/filings/0001493152-24-023350.md) | [423](/filings/0001493152-25-016071.md) | [432](/filings/0001493152-24-049468.md) | [462](/filings/0001493152-25-010016.md) | [498](/filings/0001641172-25-014351.md) | [520](/filings/0001437749-26-031469.md) | [551](/filings/0001493152-25-027060.md) | [573](/filings/0001493152-26-009820.md) | [593](/filings/0001437749-26-019975.md) | [655](/filings/0001437749-26-031469.md) |
| Total assets | $m | [499](/filings/0001493152-23-044374.md) | [522](/filings/0001493152-24-009529.md) | [517](/filings/0001493152-24-023350.md) | [550](/filings/0001493152-25-016071.md) | [555](/filings/0001493152-24-049468.md) | [576](/filings/0001493152-25-010016.md) | [601](/filings/0001641172-25-014351.md) | [626](/filings/0001437749-26-031469.md) | [655](/filings/0001493152-25-027060.md) | [678](/filings/0001493152-26-009820.md) | [698](/filings/0001437749-26-019975.md) | [764](/filings/0001437749-26-031469.md) |
| Current liabilities | $m | [276](/filings/0001493152-23-044374.md) | [285](/filings/0001493152-24-009529.md) | [278](/filings/0001493152-24-023350.md) | [279](/filings/0001493152-25-016071.md) | [270](/filings/0001493152-24-049468.md) | [278](/filings/0001493152-25-010016.md) | [287](/filings/0001641172-25-014351.md) | [293](/filings/0001437749-26-031469.md) | [305](/filings/0001493152-25-027060.md) | [308](/filings/0001493152-26-009820.md) | [308](/filings/0001437749-26-019975.md) | [352](/filings/0001437749-26-031469.md) |
| Total liabilities | $m | [282](/filings/0001493152-23-044374.md) | [291](/filings/0001493152-24-009529.md) | [283](/filings/0001493152-24-023350.md) | [284](/filings/0001493152-25-016071.md) | [272](/filings/0001493152-24-049468.md) | [281](/filings/0001493152-25-010016.md) | [290](/filings/0001641172-25-014351.md) | [296](/filings/0001437749-26-031469.md) | [307](/filings/0001493152-25-027060.md) | [310](/filings/0001493152-26-009820.md) | [310](/filings/0001437749-26-019975.md) | [356](/filings/0001437749-26-031469.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [200](/filings/0001493152-23-044374.md) | [212](/filings/0001493152-24-009529.md) | [214](/filings/0001493152-24-023350.md) | [246](/filings/0001493152-25-016071.md) | [261](/filings/0001493152-24-049468.md) | [272](/filings/0001493152-25-010016.md) | [286](/filings/0001641172-25-014351.md) | [305](/filings/0001437749-26-031469.md) | [321](/filings/0001493152-25-027060.md) | [340](/filings/0001493152-26-009820.md) | [358](/filings/0001437749-26-019975.md) | [377](/filings/0001437749-26-031469.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Current portion of debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q4 FY2024 (2024-07-31) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q4 FY2025 (2025-07-31) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) | Q4 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [14.9](/filings/0001493152-24-049468.md) | [28.4 d](/filings/0001493152-25-010016.md) | [9.5 d](/filings/0001641172-25-014351.md) | [25.4 d](/filings/0001437749-26-031469.md) | [0.2](/filings/0001493152-25-027060.md) | [20.2 d](/filings/0001493152-26-009820.md) | [75.7 d](/filings/0001437749-26-019975.md) | [31.0 d](/filings/0001437749-26-031469.md) | [(10.1)](/filings/0001493152-25-027060.md) | [38.3 d](/filings/0001493152-26-009820.md) | [18.5 d](/filings/0001437749-26-019975.md) | [44.4 d](/filings/0001437749-26-031469.md) |
| Capital expenditure | $m | [4.3](/filings/0001493152-24-049468.md) | [4.6 d](/filings/0001493152-25-010016.md) | [4.7 d](/filings/0001641172-25-014351.md) | [5.3 d](/filings/0001437749-26-031469.md) | [5.3](/filings/0001493152-25-027060.md) | [4.8 d](/filings/0001493152-26-009820.md) | [5.4 d](/filings/0001437749-26-019975.md) | [5.3 d](/filings/0001437749-26-031469.md) | [5.8](/filings/0001493152-25-027060.md) | [6.1 d](/filings/0001493152-26-009820.md) | [5.1 d](/filings/0001437749-26-019975.md) | [6.0 d](/filings/0001437749-26-031469.md) |
| Dividends paid | $m | not reported | not reported | not reported | [1.3 d](/filings/0001437749-26-031469.md) | [1.3](/filings/0001493152-25-027060.md) | [1.3 d](/filings/0001493152-26-009820.md) | [1.5 d](/filings/0001437749-26-019975.md) | [1.5 d](/filings/0001437749-26-031469.md) | [1.5](/filings/0001493152-25-027060.md) | [1.5 d](/filings/0001493152-26-009820.md) | [1.7 d](/filings/0001437749-26-019975.md) | [1.7 d](/filings/0001437749-26-031469.md) |
| Share repurchases | $m | [2.9](/filings/0001493152-24-049468.md) | [0.3 d](/filings/0001493152-25-010016.md) | [4.0 d](/filings/0001641172-25-014351.md) | [3.4 d](/filings/0001493152-25-016071.md) | [2.4](/filings/0001493152-25-027060.md) | [9.0 d](/filings/0001493152-26-009820.md) | [6.4 d](/filings/0001641172-25-014351.md) | [0.0 d](/filings/0001493152-25-016071.md) | [7.6](/filings/0001493152-25-027060.md) | [7.4 d](/filings/0001493152-26-009820.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2022-10-31) | Q2 FY2023 (2023-01-31) | Q3 FY2023 (2023-04-30) | Q1 FY2024 (2023-10-31) | Q2 FY2024 (2024-01-31) | Q3 FY2024 (2024-04-30) | Q1 FY2025 (2024-10-31) | Q2 FY2025 (2025-01-31) | Q3 FY2025 (2025-04-30) | Q1 FY2026 (2025-10-31) | Q2 FY2026 (2026-01-31) | Q3 FY2026 (2026-04-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [25.6](/filings/0001493152-23-044374.md) | [25.5](/filings/0001493152-24-009529.md) | [25.6](/filings/0001493152-24-023350.md) | [25.3](/filings/0001493152-24-049468.md) | [25.3](/filings/0001493152-25-010016.md) | [25.5](/filings/0001641172-25-014351.md) | [25.4](/filings/0001493152-25-027060.md) | [25.3](/filings/0001493152-26-009820.md) | [25.2](/filings/0001437749-26-019975.md) | [25.2](/filings/0001493152-25-027060.md) | [25.1](/filings/0001493152-26-009820.md) | [24.9](/filings/0001437749-26-019975.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:30 ET. No prices; not investment advice.